Solicitation - BARDA Accelerator Network 2. 0 - Supplemental Announcement to Fill Diagnostics and Medical Devices Hub Vacancy
Closed Solicitation Posted
- Solicitation number
- 26-BARDA-SOL-BAN_2_1
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Washington, District of Columbia, United States
- Points of contact
-
- Caleb Owen ban_inquiries@hhs.gov
Notice details come from SAM.gov. Updated .
About this opportunity
The Office of Biomedical Advanced Research and Development Authority (BARDA), operating under the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services, seeks a partner organization to establish and operate the Diagnostics/Medical Devices Hub as part of the BARDA Accelerator Network 2.0 (BAN 2.0). The procurement focuses on three core service capabilities: wraparound accelerator services including entrepreneurship education and commercialization support; Development, Evaluation, and Validation (DEV) services to source, fund, and accelerate innovators and companies; and rapid response infrastructure to support product development during public health emergencies. Respondents must be U.S.-based concerns with demonstrable experience providing these services within the past five years and building innovation ecosystem networks, with particular focus on diagnostics and devices enabling pathogen-agnostic surveillance, detection, diagnosis, and medical devices that improve casualty care and respiratory health protection. Proposals will be evaluated on a best-value basis using four weighted criteria in descending order of importance: Summary of Relevant Experience and Past Success, Organization Capabilities and Key Personnel, Program Design and Technical Approach, and Cost/Price Proposal. The proposal submission deadline is April 20, 2026, at 12:00 PM ET, with questions due by April 2, 2026, to BAN_Inquiries@hhs.gov, and BARDA anticipating awards within 90-120 days of the proposal deadline.
There is no set-aside designation for this solicitation. The incumbent contractor is University Lab Partners, operating under Other Transaction Agreement No. 75A50124C00007, with no transition period anticipated for the new hub operator. The base funding award is $2.0 million, with annual option funding of up to $2.0 million for continuing services, and a total agreement ceiling of $500 million over the period of performance to accommodate rapid response scenarios during public health emergencies. The base annual allocation includes up to $500,000 for wraparound accelerator services and up to $1.5 million for DEV services, with an average individual award of up to $200,000 per company supported through DEV funding. The agreement will consist of one base period plus six optional periods for a total of up to seven years, and the place of performance is Washington, DC. Respondents must be registered in the System for Award Management (SAM) to be eligible for consideration.
Notice text
3 versions
Update #3 · Latest ·
The Office of Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) seeks to establish a partnership to build the next iteration of the Diagnostics/Medical Devices Hub as part of the BARDA Accelerator Network (BAN 2.0) using BARDA’s Other Transaction Authority (OTA). With BAN 2.0, BARDA aims to further enhance the global health security innovation ecosystem, optimize startup acceleration and wrap-around services, and ultimately develop an Accelerator Network as a scalable infrastructure for commercialization including active product development support, and validation capabilities during regular operations as well as rapid response during public health emergencies.
Similar to the current BAN Hubs, the Diagnostics/Medical Devices Hub will support BARDA’s mission by addressing the following objectives/tasks, with a focus on innovators and companies that fit within the diagnostics/medical devices space:
- Provide wraparound acceleration services, including entrepreneurship education and access to business/commercialization and technical expertise and resources, to BARDA-aligned innovators and companies developing health security solutions.
- Provide BARDA with capabilities to source, review, fund, and accelerate innovators and companies and perform product development, evaluation, and validation of MCMs based on BARDA’s strategic priorities.
- Build a rapid emergency response infrastructure to fund and accelerate product development and validation of MCMs that can be developed and deployed as quickly as possible in the event of a public health emergency.
BARDA intends to enter into an Other Transaction Agreement with an organization to provide resources and support for the Diagnostics/Medical Devices focus area:
Diagnostics/ Medical Devices
- Focus on diagnostics and devices to enable pathogen-agnostic surveillance, detection, and diagnosis, especially at point-of-care and at-home settings, and innovative medical devices to improve the quality of casualty care, alert to the potential of an adverse health condition, simplify the collection or processing of testing samples, and protect respiratory health
The Accelerator Hub can operate independently or as a consortium of partners, though one legal entity must be identified as the prime awardee to enter into an agreement with BARDA. It is anticipated that the Accelerator Hub will provide funding and/or services to mission-relevant innovators nationally, regardless of the Hub’s physical location.
Note: The terms of this announcement supersede all prior announcements/solicitations previously issued as part of the BAN 2.0 program. All information contained in those prior versions is replaced in its entirety by this issuance. Interested parties must rely solely on this version, and any subsequent amendments to this version, for terms and conditions pertaining to submission, evaluation,and award.
Submissions are due by 12:00PM ET on April 20, 2026. Questions are due by 12:00 PM ET on April 2nd, 2026. BARDA may adjust the closing date for submissions through amendment to this notice.
Additional information is available in the attached solicitation document. Additionally, please visit https://drive.hhs.gov/.
=================================================
Edited on 3.5 to upload updated version of solicitation.
Edited on 4.6 to upload the Q and A document.
Update #2 ·
The Office of Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) seeks to establish a partnership to build the next iteration of the Diagnostics/Medical Devices Hub as part of the BARDA Accelerator Network (BAN 2.0) using BARDA’s Other Transaction Authority (OTA). With BAN 2.0, BARDA aims to further enhance the global health security innovation ecosystem, optimize startup acceleration and wrap-around services, and ultimately develop an Accelerator Network as a scalable infrastructure for commercialization including active product development support, and validation capabilities during regular operations as well as rapid response during public health emergencies.
Similar to the current BAN Hubs, the Diagnostics/Medical Devices Hub will support BARDA’s mission by addressing the following objectives/tasks, with a focus on innovators and companies that fit within the diagnostics/medical devices space:
- Provide wraparound acceleration services, including entrepreneurship education and access to business/commercialization and technical expertise and resources, to BARDA-aligned innovators and companies developing health security solutions.
- Provide BARDA with capabilities to source, review, fund, and accelerate innovators and companies and perform product development, evaluation, and validation of MCMs based on BARDA’s strategic priorities.
- Build a rapid emergency response infrastructure to fund and accelerate product development and validation of MCMs that can be developed and deployed as quickly as possible in the event of a public health emergency.
BARDA intends to enter into an Other Transaction Agreement with an organization to provide resources and support for the Diagnostics/Medical Devices focus area:
Diagnostics/ Medical Devices
- Focus on diagnostics and devices to enable pathogen-agnostic surveillance, detection, and diagnosis, especially at point-of-care and at-home settings, and innovative medical devices to improve the quality of casualty care, alert to the potential of an adverse health condition, simplify the collection or processing of testing samples, and protect respiratory health
The Accelerator Hub can operate independently or as a consortium of partners, though one legal entity must be identified as the prime awardee to enter into an agreement with BARDA. It is anticipated that the Accelerator Hub will provide funding and/or services to mission-relevant innovators nationally, regardless of the Hub’s physical location.
Note: The terms of this announcement supersede all prior announcements/solicitations previously issued as part of the BAN 2.0 program. All information contained in those prior versions is replaced in its entirety by this issuance. Interested parties must rely solely on this version, and any subsequent amendments to this version, for terms and conditions pertaining to submission, evaluation,and award.
Submissions are due by 12:00PM ET on April 20, 2026. Questions are due by 12:00 PM ET on April 2nd, 2026. BARDA may adjust the closing date for submissions through amendment to this notice.
Additional information is available in the attached solicitation document. Additionally, please visit https://drive.hhs.gov/.
=================================================
Edited on 3.5 to upload updated version of solicitation.
Update #1 ·
The Office of Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) seeks to establish a partnership to build the next iteration of the Diagnostics/Medical Devices Hub as part of the BARDA Accelerator Network (BAN 2.0) using BARDA’s Other Transaction Authority (OTA). With BAN 2.0, BARDA aims to further enhance the global health security innovation ecosystem, optimize startup acceleration and wrap-around services, and ultimately develop an Accelerator Network as a scalable infrastructure for commercialization including active product development support, and validation capabilities during regular operations as well as rapid response during public health emergencies.
Similar to the current BAN Hubs, the Diagnostics/Medical Devices Hub will support BARDA’s mission by addressing the following objectives/tasks, with a focus on innovators and companies that fit within the diagnostics/medical devices space:
- Provide wraparound acceleration services, including entrepreneurship education and access to business/commercialization and technical expertise and resources, to BARDA-aligned innovators and companies developing health security solutions.
- Provide BARDA with capabilities to source, review, fund, and accelerate innovators and companies and perform product development, evaluation, and validation of MCMs based on BARDA’s strategic priorities.
- Build a rapid emergency response infrastructure to fund and accelerate product development and validation of MCMs that can be developed and deployed as quickly as possible in the event of a public health emergency.
BARDA intends to enter into an Other Transaction Agreement with an organization to provide resources and support for the Diagnostics/Medical Devices focus area:
Diagnostics/ Medical Devices
- Focus on diagnostics and devices to enable pathogen-agnostic surveillance, detection, and diagnosis, especially at point-of-care and at-home settings, and innovative medical devices to improve the quality of casualty care, alert to the potential of an adverse health condition, simplify the collection or processing of testing samples, and protect respiratory health
The Accelerator Hub can operate independently or as a consortium of partners, though one legal entity must be identified as the prime awardee to enter into an agreement with BARDA. It is anticipated that the Accelerator Hub will provide funding and/or services to mission-relevant innovators nationally, regardless of the Hub’s physical location.
Note: The terms of this announcement supersede all prior announcements/solicitations previously issued as part of the BAN 2.0 program. All information contained in those prior versions is replaced in its entirety by this issuance. Interested parties must rely solely on this version, and any subsequent amendments to this version, for terms and conditions pertaining to submission, evaluation,and award.
Submissions are due by 12:00PM ET on April 20, 2026. Questions are due by 12:00 PM ET on April 2nd, 2026. BARDA may adjust the closing date for submissions through amendment to this notice.
Additional information is available in the attached solicitation document. Additionally, please visit https://drive.hhs.gov/.
=================================================
Files
| File | Type | Posted |
|---|---|---|
| 2026 Diagnostics Hub Q and A.docx | DOCX document | |
| BAN 2.0 Diagnostics Solicitation Update.pdf | ||
| Attachment 1 - BAN 2.0 Price Cost Workbook.xlsx | XLSX spreadsheet | |
| BAN 2.0 Diagnostics, Medical Devices Hub - Solicitation.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity